Search Results

There are 17734 results for: content related to: Vasoactive Intestinal Peptide–Mediated Th17 Differentiation

  1. You have free access to this content
    Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity

    European Journal of Biochemistry

    Volume 269, Issue 13, July 2002, Pages: 3211–3219, Salvatore De Maria, Salvatore Metafora, Vittoria Metafora, Francesco Morelli, Patrick Robberecht, Magalì Waelbroeck, Paola Stiuso, Alfredo De Rosa, Anna Cozzolino, Carla Esposito, Angelo Facchiano and Maria Cartenì

    Version of Record online : 4 AUG 2009, DOI: 10.1046/j.1432-1033.2002.02996.x

  2. In Vitro Evaluation of VIP/PACAP Receptors in Healthy and Diseased Human Tissues: Clinical Implications

    Annals of the New York Academy of Sciences

    Volume 921, Issue 1, December 2000, Pages: 1–25, JEAN CLAUDE REUBI

    Version of Record online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2000.tb06946.x

  3. You have free access to this content
    Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation

    European Journal of Biochemistry

    Volume 265, Issue 1, October (I) 1999, Pages: 449–456, Maria G. Juarranz, Jean Van Rampelbergh, Philippe Gourlet, Phillippe De Neef, Johnny Cnudde, Patrick Robberecht and Magali Waelbroeck

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00769.x

  4. Spatiotemporal distribution of vasoactive intestinal polypeptide receptor 2 in mouse suprachiasmatic nucleus

    Journal of Comparative Neurology

    Volume 520, Issue 12, 15 August 2012, Pages: 2730–2741, Sungwon An, Connie Tsai, Julie Ronecker, Alison Bayly and Erik D. Herzog

    Version of Record online : 11 JUN 2012, DOI: 10.1002/cne.23078

  5. You have free access to this content
    Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease

    Clinical & Experimental Immunology

    Volume 157, Issue 2, August 2009, Pages: 225–234, S. G. R. Smalley, P. A. Barrow and N. Foster

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1365-2249.2009.03956.x

  6. You have free access to this content
    The Neurotransmitter VIP Expands the Pool of Symmetrically Dividing Postnatal Dentate Gyrus Precursors via VPAC2 Receptors or Directs Them Toward a Neuronal Fate via VPAC1 receptors

    STEM CELLS

    Volume 27, Issue 10, October 2009, Pages: 2539–2551, Malik Zaben, W. John Sheward, Anan Shtaya, Christopher Abbosh, Anthony J. Harmar, Ashley K. Pringle and William P. Gray

    Version of Record online : 30 JUL 2009, DOI: 10.1002/stem.184

  7. You have free access to this content
    Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)

    British Journal of Pharmacology

    Volume 148, Issue 8, August 2006, Pages: 1051–1059, Ingrid Langer, Nathalie Gaspard and Patrick Robberecht

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706816

  8. You have free access to this content
    VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

    British Journal of Pharmacology

    Volume 166, Issue 1, May 2012, Pages: 42–50, Alain Couvineau and Marc Laburthe

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1476-5381.2011.01676.x

  9. You have free access to this content
    Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation

    British Journal of Pharmacology

    Volume 136, Issue 7, August 2002, Pages: 1042–1048, J Perret, P Vertongen, R M Solano, I Langer, J Cnudde, P Robberecht and M Waelbroeck

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0704802

  10. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain

    Journal of Comparative Neurology

    Volume 476, Issue 4, 30 August 2004, Pages: 388–413, Kyeung Min Joo, Yoon Hee Chung, Min Kyu Kim, Ryoung Hee Nam, Byung Lan Lee, Kyung Hoon Lee and Choong Ik Cha

    Version of Record online : 19 JUL 2004, DOI: 10.1002/cne.20231

  11. You have free access to this content
    VIP down-regulates the inflammatory potential and promotes survival of dying (neural crest-derived) corneal endothelial cells ex vivo: necrosis to apoptosis switch and up-regulation of Bcl-2 and N-cadherin

    Journal of Neurochemistry

    Volume 109, Issue 3, May 2009, Pages: 792–806, Shay-Whey M. Koh, Jason Cheng, Rebecca M. Dodson, Chao-Yar T Ku and Cara J. Abbondandolo

    Version of Record online : 24 FEB 2009, DOI: 10.1111/j.1471-4159.2009.06012.x

  12. You have free access to this content
    VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal

    British Journal of Pharmacology

    Volume 139, Issue 5, July 2003, Pages: 1050–1058, Irene Gutiérrez-Cañas, Nieves Rodríguez-Henche, Oscar Bolaños, María J Carmena, Juan C Prieto and María G Juarranz

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0705317

  13. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites

    Journal of Comparative Neurology

    Volume 475, Issue 1, 12 July 2004, Pages: 19–35, Theodosis Kalamatianos, Imre Kalló, Hugh D. Piggins and Clive W. Coen

    Version of Record online : 27 MAY 2004, DOI: 10.1002/cne.20168

  14. You have free access to this content
    Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1

    British Journal of Pharmacology

    Volume 166, Issue 1, May 2012, Pages: 4–17, Anthony J Harmar, Jan Fahrenkrug, Illana Gozes, Marc Laburthe, Victor May, Joseph R Pisegna, David Vaudry, Hubert Vaudry, James A Waschek and Sami I Said

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1476-5381.2012.01871.x

  15. You have free access to this content
    Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts

    Arthritis & Rheumatism

    Volume 58, Issue 4, April 2008, Pages: 1086–1095, Yasmina Juarranz, Irene Gutiérrez-Cañas, Begoña Santiago, Mar Carrión, José L. Pablos and Rosa P. Gomariz

    Version of Record online : 27 MAR 2008, DOI: 10.1002/art.23403

  16. You have free access to this content
    Mechanisms of VIP-induced inhibition of the lymphatic vessel pump

    The Journal of Physiology

    Volume 590, Issue 11, June 2012, Pages: 2677–2691, Pierre-Yves von der Weid, Sonia Rehal, Peter Dyrda, Stewart Lee, Ryan Mathias, Mozibur Rahman, Simon Roizes and Mohammad S. Imtiaz

    Version of Record online : 31 MAY 2012, DOI: 10.1113/jphysiol.2012.230599

  17. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors

    Hippocampus

    Volume 24, Issue 11, November 2014, Pages: 1353–1363, Diana Cunha-Reis, Maria de Fatima Aidil-Carvalho and Joaquim A. Ribeiro

    Version of Record online : 6 JUL 2014, DOI: 10.1002/hipo.22316

  18. You have free access to this content
    Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice

    Journal of Neurochemistry

    Volume 99, Issue 2, October 2006, Pages: 499–513, Beatrice A. Girard, Vincent Lelievre, Karen M. Braas, Tannaz Razinia, Margaret A. Vizzard, Yevgeniya Ioffe, Rajaa El Meskini, Gabriele V. Ronnett, James A. Waschek and Victor May

    Version of Record online : 26 JUL 2006, DOI: 10.1111/j.1471-4159.2006.04112.x

  19. The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases

    Acta Physiologica

    Volume 213, Issue 2, February 2015, Pages: 442–452, D. Ganea, K. M. Hooper and W. Kong

    Version of Record online : 11 DEC 2014, DOI: 10.1111/apha.12427

  20. You have free access to this content
    VIP and the potent analog, stearyl-Nle17-VIP, induce proliferation of keratinocytes

    FEBS Letters

    Volume 475, Issue 2, June 16, 2000, Pages: 78–83, Ruth Granoth, Mati Fridkin and Illana Gozes

    Version of Record online : 15 JUN 2000, DOI: 10.1016/S0014-5793(00)01628-8